An agonistic anti‐Toll‐like receptor 4 monoclonal antibody as an effective adjuvant for cancer immunotherapy-Reference-Cited by-同舟云学术

An agonistic anti‐Toll‐like receptor 4 monoclonal antibody as an effective adjuvant for cancer immunotherapy

Author:

Tsukamoto Hiroki¹^ORCID,Kubota Kanae¹,Shichiku Ayumi¹,Maekawa Masamitsu²,Mano Nariyasu²,Yagita Hideo³,Ohta Shoichiro⁴,Tomioka Yoshihisa¹

Affiliation:

1. Laboratory of Oncology, Pharmacy Practice and Sciences Graduate School of Pharmaceutical Sciences Tohoku University SendaiJapan

2. Department of Pharmaceutical Sciences Tohoku University Hospital SendaiJapan

3. Department of Immunology Juntendo University School of Medicine TokyoJapan

4. Department of Medical Technology and Sciences School of Health Sciences at Fukuoka International University of Health and Welfare Okawa Japan

Funder

Japan Society for the Promotion of Science

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

Reference53 articles.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献